El tribunal reactiva la demanda por mesotelioma contra Avon.
When Alicia Ramirez and her husband Fermin first filed a mesothelioma claim against Avon Products, the company successfully had the case against them dismissed. Rather than giving up, the couple doubled down and appealed the court’s decision. After close examination, the California Court of Appeal for the Second District reversed the lower court’s decision and revived the couple’s quest for justice.

Mesothelioma Victim Blames Asbestos in Avon Powder for Terminal Illness
The mesothelioma victim and her husband have been pursuing Avon since she was first diagnosed with the rare and fatal disease. They blame asbestos in the company’s talc powder products for her illness, pointing to her three-decade-long daily use of Avon talcum products as well as exposure from the Avon talc products that her daughter used in their shared bathroom.
Avon responded to the mesothelioma claim with a declaration from Lisa Gallo, vice president of global innovation, research, and development, stating that she had investigated whether the company had knowledge of asbestos in their product and had found none. Her statement, as well as documents prepared by employees of the company, supported the company’s motion for summary judgment, which was granted by Los Angeles Superior Court Judge David S. Cunningham III.
Evidence Submitted in Mesothelioma Claim Called Hearsay
In the face of their mesothelioma claim against Avon being dismissed, the Ramirez’ chose to appeal Judge Cunningham’s decision. They argued that Ms. Gallo had not begun working for Avon until 1994 and could have no personal knowledge of what the company had done or known prior to her arrival, and that an independent review conducted in her role did not comport with California’s rules of evidence. They also argued that the documents prepared by the company employees were hearsay and not admissible.
In its reversal of the lower court’s decision, the appeals court went beyond simply agreeing with the mesothelioma victim: they referred to Avon’s complaint about the rules of evidence being applied as “nonsense.” In writing for the court, presiding Justice Maria E. Stratton wrote, “What Avon is in effect suggesting is that if a party deposes a corporate entity, the corporate entity is no longer bound by the rules of evidence at any subsequent trial or hearing. This is simply nonsense.”
This ruling reinforces that asbestos defendants cannot rely on internal investigations or executive declarations to erase factual disputes in casos de mesotelioma. By rejecting Avon’s attempt to bypass evidentiary rules, the court reaffirmed that corporate testimony must be grounded in personal knowledge and admissible evidence, not retrospective conclusions crafted for litigation. For mesothelioma victims alleging exposición al amianto from consumer talc products, the decision strengthens the ability to challenge long-term product safety claims and ensures that credibility determinations remain with the jury, not corporate affidavits.
Aviso legal
La información proporcionada tiene fines educativos e informativos únicamente. La información de este sitio web no constituye asesoramiento legal y no debe utilizarse como sustituto de la consulta con un abogado colegiado. Las leyes y los resultados legales pueden variar según la jurisdicción, y solo un abogado cualificado puede ofrecerle orientación adaptada a su situación.
Sentencias como esta determinan lo que una demanda debe probar; Reclamaciones por mesotelioma y la ley que las respalda Cubre la ley subyacente. Más resoluciones: apelaciones y fallos judiciales.

Autor: Abogado de mesotelioma Paul Danziger
Paul Danziger es un destacado defensor de las víctimas de mesotelioma en todo el país. Como cofundador de Danziger & De Llano, él y su equipo han recuperado más de 1.000 millones de dólares para sus clientes y han ayudado a miles de víctimas del asbesto y a sus familias.


Paquete de compensación financiera GRATUITO
- Información sobre despachos de abogados que recuperarán su INDEMNIZACIÓN MÁS ALTA
- Aprenda cómo cobrar en 90 días
- Solicite su parte de $30 mil millones en fondos fiduciarios